Analysed ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) News Sources
Is Ultragenyx Pharmaceutical (RARE) Pricing Reflect Its Long Term Potential After 5 Year Slump
10-04-2026
yahoo.com
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
02-04-2026
yahoo.com
Patient-Funded UX016 IND Clearance Might Change The Case For Investing In Ultragenyx Pharmaceutical (RARE)
31-03-2026
yahoo.com
What is the current price of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The current price of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is $24.82.
ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) absolute price change since previous trading day?
The absolute price change of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) since the previous trading day is $0.3.
ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) percentage price change since previous trading day?
The percentage price change of ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) since the previous trading day is 1.2235%.
What is the most recent average sentiment score for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The most recent average sentiment score for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)?
The most recent sentiment for ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ) is .
SEC-8K** Filing Available For ULTRAGENYX PHARMACEUTICAL IN (RARE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.